PD‐L1 is overexpressed by many tumor types and generally correlates with progression and resistance to pro‐apoptotic stimuli (Azuma et al, 2008; Gato‐Canas et al, 2017; Juneja et al, 2017). This evidence concerns the gene CD274 and neoplasm.